Jump to content

Corticorelin

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Moondyne (talk | contribs) at 10:22, 18 August 2016 (add Category:World Anti-Doping Agency prohibited substances using AWB). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Corticorelin
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
CAS Number
PubChem CID
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC205H339N59O63S
Molar mass4670.31 g/mol g·mol−1
  (verify)

Corticorelin (INN) is a diagnostic agent. It is a synthetic form of human corticotropin-releasing hormone (hCRH).[1]

The corticorelin stimulation test helps to differentiate between the etiologies of adrenocorticotropic hormone (ACTH)-dependent hypercortisolism. It is used to evaluate the status of the pituitary-adrenal axis in the differentiation of a pituitary source from an ectopic source of excessive ACTH secretion.

  • If corticorelin injection increases plasma levels of ACTH and cortisol, a diagnosis of Cushing's disease is achieved (ACTH of pituitary origin).
  • If corticorelin injection leads to little or no response in plasma levels of ACTH or cortisol, a diagnosis of ectopic ACTH syndrome is confirmed.

See also

References

  1. ^ Andoh K, Kimura T, Saeki I, et al. (June 1994). "General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human)". Arzneimittelforschung. 44 (6): 715–26. PMID 8053970.

Template:Neuropeptidergics